A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Healthy Males
Stopped Study recruitment was terminated on 14 June 2016 due to a Pfizer business decision. This study was not terminated for reasons of safety.
Conditions
Interventions
- DRUG: PF-06412562 3mg BID
- DRUG: PF-06412562 15mg BID
- OTHER: Placebo
Sponsor
Pfizer